Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
暂无分享,去创建一个
U. Steinbrecher | L. Blendis | K. O'rourke | R. Bailey | G. Minuk | E. Heathcote | C. Williams | K. Cauch‐Dudek | C. Ghent | S. Pappas | L. Scully | L. R. Sutherland | L. Worobetz | M. R. Kilmurry
[1] E. Dickson,et al. Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis , 1995 .
[2] P. Grambsch,et al. Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits , 1994, Hepatology.
[3] B. Balkau,et al. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.
[4] E. Dickson,et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.
[5] U. Steinbrecher,et al. The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.
[6] M. Bennett,et al. A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Journal of gastroenterology and hepatology.
[7] B. Balkau,et al. Predictive factors in ursodeoxycholic acid‐treated patients with primary biliary Cirrhosis: Role of serum markers of connective tissue , 1994, Hepatology.
[8] D G Altman,et al. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. , 1993, Gastroenterology.
[9] A. West,et al. A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1993, Hepatology.
[10] F. Bianchi,et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC. , 1993, Journal of hepatology.
[11] B. Balkau,et al. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.
[12] J. Neuberger,et al. Referral of patients with primary biliary cirrhosis for liver transplantation. , 1990, Gut.
[13] G. Bonsel,et al. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis , 1990, The Lancet.
[14] K. Hübner,et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. , 1989, Gastroenterology.
[15] P. Grambsch,et al. Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.
[16] D. Altman,et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. , 1985, Gastroenterology.
[17] D. Altman,et al. Beneficial Effect of Azathioprine and Prediction of Prognosis in Primary Biliary , 1985 .
[18] J. Boyer,et al. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. , 1983, The New England journal of medicine.
[19] F. Schaffner,et al. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. , 1979, Gut.
[20] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .